Theragen Inc. launched a personal genome typing service similar to 23andme's. However, the product was withheld due to legal issues.

From Biolecture.org
Revision as of 03:57, 22 March 2010 by J (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

In Korea, there is a strict law preventing companies to perform non-diagnostic genetic experiment and analysis to make profit.

Retrieved from "http://Biolecture.org/index.php?title=Theragen_Inc._launched_a_personal_genome_typing_service_similar_to_23andme%27s._However,_the_product_was_withheld_due_to_legal_issues.&oldid=2913"